{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Restrict the search for
m acetohexamide
to a specific field?
Status:
Possibly Marketed Outside US
Source:
IMUBOLIC by Ayurax
(2022)
Source URL:
First approved in 2021
Source:
NMN.5S by Chengdu Heqi Cosmetics Co., Ltd
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT03530124: Phase 4 Interventional Completed Apnea
(2018)
Source URL:
First approved in 2021
Source:
Jointox BB by Energique, Inc.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2020)
Source URL:
First approved in 2020
Source:
21 CFR 333A
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
NCT02054455: Phase 4 Interventional Completed Gastrointestinal Symptoms
(2012)
Source URL:
First approved in 2020
Source:
BACICAP PROBIOTIC by NATIONAL BIO GREEN SCIENCES LIMITED LIABILTY COMPANY
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Lamwave antimicrobial hand sanitizers gel by Guangzhou Youmei Biotechnology Co., Ltd.
Source URL:
First approved in 2020
Source:
Lamwave antimicrobial hand sanitizers gel by Guangzhou Youmei Biotechnology Co., Ltd.
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333A
(2020)
Source URL:
First approved in 2020
Source:
21 CFR 333A
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
Provad by TMIG Inc
(2019)
Source URL:
First approved in 2019
Source:
Provad by TMIG Inc
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
MINOXIGAINE by Hairgenics LLC
(2019)
Source URL:
First approved in 2019
Source:
MINOXIGAINE by Hairgenics LLC
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
BLA125563
(2018)
Source URL:
First approved in 2018
Source:
BLA125563
Source URL:
Class:
STRUCTURALLY DIVERSE
Status:
Possibly Marketed Outside US
Source:
M020
(2018)
Source URL:
First approved in 2018
Source:
M020
Source URL:
Class:
STRUCTURALLY DIVERSE